These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36755374)

  • 1. Roxadustat induces hepatotoxicity in zebrafish embryos via inhibiting Notch signaling.
    Yang D; Xiao J; Wan M; Liu J; Huang L; Li X; Zhang L; Liu F; Liang D; Zheng Y; Xie B; Liao X; Xiong G; Lu H; Cao Z; Zhang S
    J Appl Toxicol; 2023 Jul; 43(7):1073-1082. PubMed ID: 36755374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lenvatinib exposure induces hepatotoxicity in zebrafish via inhibiting Wnt signaling.
    Huang L; Liu J; Li W; Liu F; Wan M; Chen G; Su M; Guo C; Han F; Xiong G; Liao X; Lu H; Cao Z
    Toxicology; 2021 Oct; 462():152951. PubMed ID: 34534561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine A induces hepatotoxicity in zebrafish larvae via upregulating oxidative stress.
    Wan M; Xiao J; Liu J; Yang D; Wang Y; Liu J; Huang L; Liu F; Xiong G; Liao X; Lu H; Cao Z; Zhang S
    Comp Biochem Physiol C Toxicol Pharmacol; 2023 Apr; 266():109560. PubMed ID: 36720376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonclinical Characterization of the Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat, a Novel Treatment of Anemia of Chronic Kidney Disease.
    Del Balzo U; Signore PE; Walkinshaw G; Seeley TW; Brenner MC; Wang Q; Guo G; Arend MP; Flippin LA; Chow FA; Gervasi DC; Kjaergaard CH; Langsetmo I; Guenzler V; Liu DY; Klaus SJ; Lin A; Neff TB
    J Pharmacol Exp Ther; 2020 Aug; 374(2):342-353. PubMed ID: 32487538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pamiparib Induces Neurodevelopmental Defects and Cerebral Haemorrhage in Zebrafish Embryos via Inhibiting Notch Signalling.
    Yang D; Liu F; Wan M; Liu J; Huang L; Chen C; Li X; Zhang L; Ding X; Liao X; Xiong G; Lu H; Xiao J; Cao Z
    Mol Neurobiol; 2022 Nov; 59(11):6652-6665. PubMed ID: 35982279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Carcinogenic Potential of Roxadustat (FG-4592), a Small Molecule Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase in CD-1 Mice and Sprague Dawley Rats.
    Beck J; Henschel C; Chou J; Lin A; Del Balzo U
    Int J Toxicol; 2017; 36(6):427-439. PubMed ID: 29153032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lenvatinib induces cardiac developmental toxicity in zebrafish embryos through regulation of Notch mediated-oxidative stress generation.
    Liu J; Huang L; Wan M; Chen G; Su M; Han F; Liu F; Xiong G; Liao X; Lu H; Li W; Cao Z
    Environ Toxicol; 2022 Jun; 37(6):1310-1320. PubMed ID: 35119177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roxadustat, a HIF-PHD inhibitor with exploitable potential on diabetes-related complications.
    Fang T; Ma C; Zhang Z; Sun L; Zheng N
    Front Pharmacol; 2023; 14():1088288. PubMed ID: 36843948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyhalofop-butyl exposure induces the severe hepatotoxicity and immunotoxicity in zebrafish embryos.
    Xiong G; Hu H; Zhang H; Zhang J; Cao Z; Lu H; Liao X
    Fish Shellfish Immunol; 2023 Mar; 134():108644. PubMed ID: 36842639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roxadustat, a Hypoxia-Inducible Factor 1α Activator, Attenuates Both Long- and Short-Term Alcohol-Induced Alcoholic Liver Disease.
    Gao Y; Jiang X; Yang D; Guo W; Wang D; Gong K; Peng Y; Jiang H; Shi C; Duan Y; Chen Y; Han J; Yang X
    Front Pharmacol; 2022; 13():895710. PubMed ID: 35620283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporine A Induces Cardiac Developmental Toxicity in Zebrafish by Up-Regulation of Wnt Signaling and Oxidative Stress.
    Wan M; Huang L; Liu J; Liu F; Chen G; Ni H; Xiong G; Liao X; Lu H; Xiao J; Tao Q; Cao Z
    Front Pharmacol; 2021; 12():747991. PubMed ID: 34867350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A network meta-analysis of the efficacy of hypoxia-inducible factor prolyl-hydroxylase inhibitors in dialysis chronic kidney disease.
    Chen J; Shou X; Xu Y; Jin L; Zhu C; Ye X; Mei Z; Chen P
    Aging (Albany NY); 2023 Mar; 15(6):2237-2274. PubMed ID: 36988549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whether Prolyl Hydroxylase Blocker-Roxadustat-In the Treatment of Anemia in Patients with Chronic Kidney Disease Is the Future?
    Grzeszczak W; Szczyra D; Śnit M
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33567688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Renal Anemia in Patients With Hemodialysis Using Hypoxia-inducible Factor (HIF) Stabilizer, Roxadustat: A Short-term Clinical Study.
    Mima A; Horii Y
    In Vivo; 2022; 36(4):1785-1789. PubMed ID: 35738640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the Capability of Roxadustat (FG-4592), an Oral HIF Prolyl-Hydroxylase Inhibitor, to Perturb Membrane Ionic Currents: An Unidentified yet Important Action.
    Chang WT; Lo YC; Gao ZH; Wu SN
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat on renal anemia in non-dialysis-dependent chronic kidney disease: a systematic review and meta-analysis.
    Jia L; Dong X; Yang J; Jia R; Zhang H
    Ann Transl Med; 2019 Dec; 7(23):720. PubMed ID: 32042736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roxadustat promotes angiogenesis through HIF-1α/VEGF/VEGFR2 signaling and accelerates cutaneous wound healing in diabetic rats.
    Zhu Y; Wang Y; Jia Y; Xu J; Chai Y
    Wound Repair Regen; 2019 Jul; 27(4):324-334. PubMed ID: 30817065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Mixed Lymphocyte Reaction, the Hypoxia-Inducible Factor Prolyl-Hydroxylase Inhibitor Roxadustat Suppresses Cellular and Humoral Alloimmunity.
    Eleftheriadis T; Pissas G; Mavropoulos A; Nikolaou E; Filippidis G; Liakopoulos V; Stefanidis I
    Arch Immunol Ther Exp (Warsz); 2020 Oct; 68(6):31. PubMed ID: 33011826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roxadustat: Not just for anemia.
    Zhu X; Jiang L; Wei X; Long M; Du Y
    Front Pharmacol; 2022; 13():971795. PubMed ID: 36105189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience With the Use of a Novel Agent, Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, for Posttransplant Anemia in Renal Transplant Recipients: A Case Report.
    Naganuma T; Iwai T; Takemoto Y; Uchida J
    Transplant Proc; 2022 Mar; 54(2):544-548. PubMed ID: 35120763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.